Clinical trials show that tirzepatide users experience larger weight reductions on average than semaglutide users at equivalent timepoints
and James, S.J
Noticeable brightening typically occurs after 46 sessions
Individuals with central obesity, insulin resistance, elevated triglycerides, low HDL cholesterol, and high blood pressure face dramatically elevated cardiovascular risk
Available from: J L Sievenpiper 1 2 3 , J Ard 4 , M Blher 5 , W Chen 6 , J B Dixon 7 , A Fitch 8 , L Gigliotti 9 , K Khunti 10 , A Lecube 11 12 , M E J Lean 13 , B Mittendorfer 14 , A F H Pfeiffer 15 , D H Ryan 16 , T Vilsbll 17 18 , L F Van Gaal 19
Proven Results Clinical studies show that Semaglutide users experience significant weight loss up to 15-20% of body weight in just 6-8 weeks